These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39278148)

  • 1. Return to work and self-reported swallowing following transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma: A retrospective cohort study.
    Staibano P; Au M; Xie M; Gupta MK; Young JEMT; Zhang H
    Oral Oncol; 2024 Dec; 159():107033. PubMed ID: 39278148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
    Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?
    Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R
    Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Functional and Quality-of-Life Outcomes After Transoral Robotic Surgery in Patients With Oropharyngeal Cancer.
    Achim V; Bolognone RK; Palmer AD; Graville DJ; Light TJ; Li R; Gross N; Andersen PE; Clayburgh D
    JAMA Otolaryngol Head Neck Surg; 2018 Jan; 144(1):18-27. PubMed ID: 29075740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity.
    Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD;
    Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma: Secondary Analysis of the PATHOS Randomized Clinical Trial.
    O'Hara JT; Hurt CN; Ingarfield K; Patterson JM; Hutcheson K; Canham JE; Nixon LS; Heiberg CD; Johson S; Evans M; Jones TM
    JAMA Otolaryngol Head Neck Surg; 2024 Oct; 150(11):1002-11. PubMed ID: 39388196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early return to work is possible after transoral robotic surgery (TORS) in carefully selected patients with oropharyngeal squamous cell carcinoma.
    Green L; McDowell L; Ip F; Tapia M; Zhou M; Fahey MT; Dixon B; Magarey M
    Oral Oncol; 2024 Dec; 159():107032. PubMed ID: 39293101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis.
    Gupta KK; De M; Athanasiou T; Georgalas C; Garas G
    Eur J Surg Oncol; 2024 Jul; 50(7):108434. PubMed ID: 38795678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
    Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
    BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer.
    Hutcheson KA; Warneke CL; Yao CMKL; Zaveri J; Elgohari BE; Goepfert R; Hessel AC; Kupferman ME; Lai SY; Fuller CD; Gunn GB; Garden AS; Johnson F; Ferrarotto R; Lewin JS; Gross ND;
    JAMA Otolaryngol Head Neck Surg; 2019 Nov; 145(11):1053-1063. PubMed ID: 31556933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer.
    Barbon CEA; Yao CMK; Peterson CB; Moreno AC; Goepfert RP; Johnson FM; Chronowski GM; Fuller CD; Gross ND; Hutcheson KA
    Otolaryngol Head Neck Surg; 2022 Sep; 167(3):484-493. PubMed ID: 34784256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
    Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
    Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ
    Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.